MENU
NRXS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Neuraxis (NRXS) Ownership - Who owns Neuraxis?
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more
Profile
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.91M
P/E Ratio
N/A
Total Cash
2.01M
Projected Growth
N/A
Total Debt
388.74K
Revenue
2.93M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.41 USD as % of share price
Fundamentals
NRXS
Capitalization
21.9M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
2.01M
Total Cash/Share
0.21
Total Debt
389K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.41%
Revenue
2.94M
ROE
N/A
Book Value
254K
P/B Ratio
86.21
Cash Flow
N/A
Earnings
-1.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.22K
Current Ratio
1.21
Current Revenue Per Employee
42650.24
Dividends Per Share - Security
N/A
EBITDA
-8.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
84.43
Revenue To Assets
-443.93
Shares Held By Institutions
1.11M
Shares Outstanding - Current
9.53M
Total Liabilities
2.77M
Total Volume MTD
N/A
Value
-1
Gain YTD
-2.128
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com